NCT02268981
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Klinikum Berchtesgadener Land der Schön-Kliniken Schönau am Königssee, Bavaria, Germany
Clinical trial condition
Pulmonary Fibrosis
Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.
374 public trials
55 recruiting studies
Pulmonary Fibrosis trial results
NCT01817686
- Conditions
- Any Stage 3B or 4 Solid Tumor, COPD, Cardiovascular Diseases, +19 more
- Locations
-
- Philadelphia Veterans Affairs Medical Center Philadelphia, Pennsylvania, United States
NCT00453713
- Conditions
- Diffuse Parenchymal Lung Disease, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, +4 more
- Locations
-
- Columbia University Medical Center New York, United States
NCT00125385
- Conditions
- Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
- Locations
-
- Denver, Colorado, United States
- Chicago, Illinois, United States
- Ann Arbor, Michigan, United States
- Minneapolis, Minnesota, United States
NCT01777373
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Hôpital Bichat Paris, France
NCT01118221
- Conditions
- Behavior, Idiopathic Pulmonary Fibrosis, Lung Diseases, +4 more
- Locations
-
- VA Medical Center, Miami Miami, Florida, United States
NCT01136174
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- 1199.31.002 Boehringer Ingelheim Investigational Site Bunkyo-ku,Tokyo, Japan
- 1199.31.004 Boehringer Ingelheim Investigational Site Hamamatsu, Shizuoka, Japan
- 1199.31.008 Boehringer Ingelheim Investigational Site Himeji, Hyogo, Japan
- 1199.31.006 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan
Completed
IPF Drug Deposition Study
NCT01457261
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Royal Brompton Hospital London, United Kingdom
Completed
Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
NCT02136992
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
Not specified
NCT00903331
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Pulmonary Associates, P.A. Phoenix, Arizona, United States
- Mayo Clinic - Arizona Scottsdale, Arizona, United States
- U.C. Davis University of California Sacramento, California, United States